Ara
Toplam kayıt 2, listelenen: 1-2
ESCMID COVID-19 Living Guidelines: Drug Treatment And Clinical Management
(2022)
Scope: In January 2021, the ESCMID Executive Committee decided to launch a new initiative to develop ESCMID guidelines on several COVID-19-related issues, including treatment of COVID-19.
Methods: An ESCMID COVID-19 ...
Treatment of ventilator-associated pneumonia (VAP) caused by Acinetobacter: results of prospective and multicenter ID-IRI study
(2020)
Ventilator-associated pneumonia (VAP) due to Acinetobacter spp. is one of the most common infections in the intensive care unit. Hence, we performed this prospective-observational multicenter study, and described the course ...